Table 5 Correlations between BLM expression and clinicopathological characteristics of PCa patients
Clinicopathological characteristics | N (90) | BLM | X2 | P value | |
|---|---|---|---|---|---|
Positive (%) | Negative (%) | ||||
Age (years) | 1.327 | 0.185 | |||
 ≤ 70 | 49 | 33 (61.2) | 16 (38.8) |  |  |
 > 70 | 41 | 22 (53.7) | 19 (17.9) |  |  |
T status | 2.288 | 0.022 | |||
 T1–T2 | 26 | 18 (69.2) | 8 (30.8) |  |  |
 T3–T4 | 64 | 57 (89.1) | 7 (10.9) |  |  |
Gleason grade | 2.743 | 0.006 | |||
 1–3 | 37 | 25 (67.6) | 12 (32.4) |  |  |
 4–5 | 53 | 48 (90.6) | 5 (9.4) |  |  |
N-regional lymph nodes | 1.927 | 0.054 | |||
 N0 | 46 | 32 (69.6) | 18 (39.1) |  |  |
 N1 | 44 | 36 (95.5) | 8 (4.5) |  |  |
M-Distant metastasis | 1.001 | 0.312 | |||
 M0 | 88 | 58 (65.9) | 30 (34.1) |  |  |
 M1 | 2 | 2 (100) | 0 (0) |  |  |